Cofactor Genomics acquires Narus; ups focus on RNA diagnostics
In a move that will clearly up its focus on RNA diagnostics, St. Louis-based Cofactor Genomics has acquired San Francisco's Narus Biotechnologies.
Diagnostics could be one of the smartest places for a startup to be right now in healthcare
Diagnostics could soon become a whole lot better, and people are investing in it. Heavily.
Why Pharma Companies Should Look To Social Media For Better Patient Insight
Healthcare decision-makers, especially at pharmaceutical companies, must prioritize patient input. Data collected from social media listening is a significant step in the right direction.